BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal ...

Drs Kathy Miller and Francisco J. Esteva discuss testing and therapeutic options for the new classification of HER2-ultra-low breast cancer.

The parents could visit the hospital only once for a checkup following the surgery and one more physical consultation is ...

A Bangladeshi couple is facing visa challenges for their nine-month-old son's post-surgery checkup in Kolkata, India. Their ...

As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...

With an accuracy of 86%, the biomarker panel has the potential to be clinically useful in diagnosis, management, and ...

There’s no evidence that male enhancement pills can increase penis size, but for people experiencing erectile dysfunction, there are treatment options available. The male enhancement pills ...

12月4日，港股创新药企云顶新耀（HKEX 1952.HK）发布了其拥有全球权益的新一代共价可逆布鲁顿酪氨酸激酶（BTK）抑制剂EVER001（又名：XNW1011），在治疗原发性膜性肾病（primary membranous nephropathy ...

12月4日，港股创新药企云顶新耀（HKEX 1952.HK）发布了其拥有全球权益的新一代共价可逆布鲁顿酪氨酸激酶（BTK）抑制剂EVER001（又名：XNW1011），在治疗原发性膜性肾病（primary membranous nephropathy ...

EVER001 (previously known as XNW1011) is a next-generation covalent reversible Bruton’s tyrosine kinase (BTK) inhibitor in development globally for the treatment of renal diseases. BTK is an essential ...

Webcast Link: https://www.acecamptech.com/meeting_live/70512679/774680?event_id=60510700 EVER001 (previously known as XNW1011) is a next-generation covalent ...